XRK3F2 B
CAS No. 2375193-43-2
XRK3F2 B( —— )
Catalog No. M33173 CAS No. 2375193-43-2
XRK3F2 is an inhibitor of the p62-ZZ domain, blunts MM-induced Runx2 suppression in vitro, and induces new bone formation and remodeling in the presence of tumor in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 52 | Get Quote |
|
| 5MG | 75 | Get Quote |
|
| 10MG | 116 | Get Quote |
|
| 25MG | 217 | Get Quote |
|
| 50MG | 342 | Get Quote |
|
| 100MG | 503 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameXRK3F2 B
-
NoteResearch use only, not for human use.
-
Brief DescriptionXRK3F2 is an inhibitor of the p62-ZZ domain, blunts MM-induced Runx2 suppression in vitro, and induces new bone formation and remodeling in the presence of tumor in vivo.
-
DescriptionXRK3F2 is an inhibitor of p62 (Sequestosome-1)-ZZ/domain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2375193-43-2
-
Formula Weight435.89
-
Molecular FormulaC23H24ClF2NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 150 mg/mL (344.12 mM; Ultrasonic )H2O : 0.91 mg/mL (2.09 mM; Ultrasonic)
-
SMILESCl.OCCNCc1ccc(OCc2ccc(F)cc2)c(OCc2ccc(F)cc2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Adamik J, et al. XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression. Front Endocrinol (Lausanne). 2018 Jun 29;9:344.?
molnova catalog
related products
-
Sulfacetamide sodium
Sulfacetamide Sodium is an anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.
-
Hemin
Hemin, a physiological erythroid maturation stimulator, is able to induce the expression of critical autophagic genes (Map1a1b (LC3), Beclin-1 gen, Atg5) in an erythroleukemia cell type.
-
Imiquimod maleate
Imiquimod maleate (R 837 maleate) is a toll-like receptor 7 (TLR7) agonist and immune response modifier with antiviral and antitumor effects.
Cart
sales@molnova.com